Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Li, Yanzhang ^a   Tong, Xiaopeng ^a   Rumala, Courtney ^a   Clemons, Kate ^a   Wang, Shuxia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; THROMBOSPONDIN 1; PRIMER DNA;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CELL AGGREGATION; CELL MOTILITY; CONTROLLED STUDY; GLUCOSE TOLERANCE; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; LOW FAT DIET; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; THROMBOSPONDIN 1 DEFICIENCY; WILD TYPE; ANIMAL; C57BL MOUSE; DIET; DISEASE MODEL; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; BASE SEQUENCE; DIET; DISEASE MODELS, ANIMAL; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1;

EID: 80055039168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026656     Document Type: Article

References (43)

1. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
2. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
3. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, et al. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 282: 35279-35292.
4. Lumeng CN, Bodzin JL, Saltiel AR, (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184.
5. Lawler JW, Slayter HS, Coligan JE, (1978) Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 253: 8609-8616.
6. Baenziger NL, Brodie GN, Majerus PW, (1971) A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A 68: 240-243.
7. Donoviel DB, Amacher SL, Judge KW, Bornstein P, (1990) Thrombospondin gene expression is associated with mitogenesis in 3T3 cells: induction by basic fibroblast growth factor. J Cell Physiol 145: 16-23.
8. Phelan MW, Forman LW, Perrine SP, Faller DV, (1998) Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med 132: 519-529.
9. Bornstein P, (2001) Thrombospondins as matricellular modulators of cell function. J Clin Invest 107: 929-934.
10. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, et al. (1995) Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48: 1846-1856.
11. Mikhailenko I, Krylov D, Argraves KM, Roberts DD, Liau G, et al. (1997) Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein. J Biol Chem 272: 6784-6791.
12. Goicoechea S, Orr AW, Pallero MA, Eggleton P, Murphy-Ullrich JE, (2000) Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J Biol Chem 275: 36358-36368.
13. Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, et al. (2000) Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell 11: 2885-2900.
14. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, et al. (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6: 41-48.
15. Frazier WA, Gao AG, Dimitry J, Chung J, Brown EJ, et al. (1999) The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 274: 8554-8560.
16. Wang S, Herndon ME, Ranganathan S, Godyna S, Lawler J, et al. (2004) Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans. J Cell Biochem 91: 766-776.
17. Lawler J, Weinstein R, Hynes RO, (1988) Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 107: 2351-2361.
18. Murphy-Ullrich JE, Mosher DF, (1987) Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol 105: 1603-1611.
19. Taraboletti G, Roberts DD, Liotta LA, (1987) Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 105: 2409-2415.
20. Mansfield PJ, Suchard SJ, (1994) Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 153: 4219-4229.
21. Martin-Manso G, Galli S, Ridnour LA, Tsokos M, Wink DA, et al. (2008) Thrombospondin 1 Promotes Tumor Macrophage Recruitment and Enhances Tumor Cell Cytotoxicity of Differentiated U937 Cells. Cancer Res 68: 7090-7099.
22. Olson BA, Day JR, Laping NJ, (1999) Age-related expression of renal thrombospondin 1 mRNA in F344 rats: resemblance to diabetes-induced expression in obese Zucker rats. Pharmacology 58: 200-208.
23. Ramis JM, Franssen-van Hal NL, Kramer E, Llado I, Bouillaud F, et al. (2002) Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell Mol Life Sci 59: 1960-1971.
24. Shang CA, Thompson BJ, Teasdale R, Brown RJ, Waters MJ, (2002) Genes induced by growth hormone in a model of adipogenic differentiation. Mol Cell Endocrinol 189: 213-219.
25. Okuno M, Arimoto E, Nishizuka M, Nishihara T, Imagawa M, (2002) Isolation of up- or down-regulated genes in PPARgamma-expressing NIH-3T3 cells during differentiation into adipocytes. FEBS Lett 519: 108-112.
26. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, et al. (2005) Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 146: 4545-4554.
27. Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, et al. (2008) Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57: 432-439.
28. Frolova EG, Pluskota E, Krukovets I, Burke T, Drumm C, et al. (2010) Thrombospondin-4 regulates vascular inflammation and atherogenesis. Circ Res 107: 1313-1325.
29. de Luca C, Olefsky JM, (2008) Inflammation and insulin resistance. FEBS Lett 582: 97-105.
30. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309.
31. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025.
32. Voros G, Lijnen HR, (2006) Deficiency of thrombospondin-1 in mice does not affect adipose tissue development. J Thromb Haemost 4: 277-278.
33. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J, (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295: E1323-1332.
34. Wu H, Perrard XD, Wang Q, Perrard JL, Polsani VR, et al. (2010) CD11c expression in adipose tissue and blood and its role in diet-induced obesity. Arterioscler Thromb Vasc Biol 30: 186-192.
35. McMaken S, Exline MC, Mehta P, Piper M, Wang Y, et al. (2011) Thrombospondin-1 Contributes to Mortality in Murine Sepsis through Effects on Innate Immunity. PLoS One 6: e19654.
36. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, et al. (1998) Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93: 1159-1170.
37. Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, et al. (2004) Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int 65: 459-468.
38. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE, (1994) The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem 269: 26783-26788.
39. Schultz-Cherry S, Murphy-Ullrich JE, (1993) Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122: 923-932.
40. Young GD, Murphy-Ullrich JE, (2004) Molecular interactions that confer latency to transforming growth factor-beta. J Biol Chem 279: 38032-38039. Epub 32004 Jun 38018.
41. Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, et al. (2000) Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49: 1374-1380.
42. Samad F, Yamamoto K, Pandey M, Loskutoff DJ, (1997) Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med 3: 37-48.
43. Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, et al. (2006) Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond) 30: 1308-1314.